Sotabase

Career

· Researcher, Sable Research Group, McGill University2024–
· Marketing Consultant, Telamon Communications2009–
· Marketing Manager, Market Research Benevolent Association (MRBA)2008–
· Marketing Contract Roles, Somerset County Council2005–
· International Marketing Director, TNS1994–2005
· Consultant, BW Consulting
· Genetic Alliance UK
· OpenAir Networks
· Chairman, Oxford University Hospitals Foundation Trust
· Appeals Board Member, PMCPA part of ABPI
· Non-Executive Director, PMCPA part of ABPI
· University of Portsmouth

Publications (44)

AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress.
Blood · 2015
277
cited
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
BMC Cancer · 2010
164
cited
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies
American journal of hematology/oncology · 2014
90
cited
Mitochondrial matrix proteases as novel therapeutic targets in malignancy
Oncogene · 2014
76
cited
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia
PLoS ONE · 2014
74
cited
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies
Core Evidence · 2013
72
cited
Differential interactions between statins and P‐glycoprotein: Implications for exploiting statins as anticancer agents
International Journal of Cancer · 2010
71
cited
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells
Breast Cancer Research and Treatment · 2013
65
cited
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death
OncoTarget · 2015
63
cited
Expression of RBM5‐related factors in primary breast tissue
Journal of Cellular Biochemistry · 2007
62
cited
A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity
PLoS ONE · 2014
39
cited
The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein
Cell Biochemistry and Function · 2007
14
cited
A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus
Molecular Oncology · 2007
9
cited
"I Built My House of Hope:" Best Practices to Safely House Abused and Homeless Women
2009
7
cited
Abstract PR12: A genome-wide shRNA screen reveals that inhibiting kinases potentiates the anti-breast cancer activity of fluvastatin
2013
1
cited
Procedural Factors in Children's Class Inclusion
1982
1
cited
169 Identifying molecular hallmarks of sensitivity to the anticancer effects of statins in breast tumour cells
2010
Abstract 3543: Targeting the metabolic mevalonate pathway with statins as anti-breast cancer agents
2017
Abstract #5543: Lovastatin induces apoptosis of ovarian cancer cells and modulates the efficacy of chemotherapeutics: Implications for patient treatment
2009
Abstract C165: Breast cancer, statins, and 3-D cell culture.
2011
Sotabase
Chris Goard | Researcher Profile | Sotabase | Sotabase